What psychotherapists should know about pharmacotherapies for bipolar disorder
✍ Scribed by Joseph F. Goldberg
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 128 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0021-9762
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This article provides a practice‐friendly overview of current psychotropic agents used for the treatment of bipolar disorder. The author reviews definitions and concepts about mood stabilization according to the evidence base, in turn profiling a “clinical niche” for lithium, anticonvulsant drugs, atypical antipsychotics, and antidepressants. Results from randomized clinical trials are summarized to help clinicians individualize treatment decisions and tailor them to real‐world patients. Recognition and management of common adverse effects are discussed alongside risk–benefit strategies to guide optimal treatment that balances clinical efficacy with drug safety and tolerability. © 2007 Wiley Periodicals, Inc. J Clin Psychol: In Session 63: 475–490, 2007.